Strength
200 mg/1
Manufacturer
Edenbridge Pharmaceuticals LLCNDC
42799011002
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ALBENDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA211117On Market Since
5/17/2019
Pharmacological Classes
Anthelmintic
Cytochrome P450 1A Inducers